Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States

被引：0
|
作者：
Shujing Zhang
Arielle G. Bensimon
Ruifeng Xu
Ruixuan Jiang
Alexandra Greatsinger
Adina Zhang
Mizuho Fukunaga-Kalabis
Clemens Krepler
机构：
[1] Merck & Co.,
[2] Inc.,undefined
[3] Analysis Group,undefined
[4] Inc.,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Adjuvant treatment; Cost-effectiveness analysis; Pembrolizumab; Stage IIB–IIC melanoma; US health sector perspective;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3038 / 3055
页数：17
相关论文
共 50 条
  • [31] A cost-effectiveness analysis of adjuvant therapies for resected adenocarcinoma of the rectum.
    Lee, JH
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 235 - 235
  • [32] Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection
    Lopez-Vinueza, Cesar
    Urrego-Reyes, Juan
    Gutierrez, Fredy R. S.
    Wurcel, Victoria
    Zhang, Shujing
    Jiang, Shan
    Jiang, Ruixuan
    Harvey, Angela Zambrano
    Dhankhar, Praveen
    Sawhney, Baanie
    Baluni, Gargi
    Jain, Shrishti
    Bhadra, Debosmita
    ADVANCES IN THERAPY, 2023, 40 (06) : 2836 - 2854
  • [33] Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection
    Cesar Lopez-Vinueza
    Juan Urrego-Reyes
    Fredy R. S. Gutierrez
    Victoria Wurcel
    Shujing Zhang
    Shan Jiang
    Ruixuan Jiang
    Angela Zambrano Harvey
    Praveen Dhankhar
    Baanie Sawhney
    Gargi Baluni
    Shrishti Jain
    Debosmita Bhadra
    Advances in Therapy, 2023, 40 : 2836 - 2854
  • [34] Cost-effectiveness analysis in the United States - Reply
    Pearson, SD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (23): : 2722 - 2723
  • [35] Cost-effectiveness of HIV testing and treatment in the United States
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    Weinstein, Milton C.
    Paltiel, A. David
    CLINICAL INFECTIOUS DISEASES, 2007, 45 : S248 - S254
  • [36] Modelling the cost-effectiveness of sentinel lymph node mapping and adjuvant interferon treatment for stage II melanoma
    Wilson, LS
    Reyes, CM
    Lu, C
    Lu, M
    Yen, C
    MELANOMA RESEARCH, 2002, 12 (06) : 607 - 617
  • [37] Cost-effectiveness of an intensive follow-up protocol for patients with AJCC stages IIB, IIC, and III malignant melanoma
    Podlipnik, Sebastian
    Moreno, David
    Carrera, Cristina
    Barreiro, Alicia
    Manubens, Elena
    Ferrandiz-Pulido, Lara
    Sanchez, Marcelo
    Vidal-Sicart, Sergi
    Malvehy, Josep
    Puig, Susana
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB89 - AB89
  • [38] Cost-Effectiveness Analysis of Chemoradiation and Radiotherapy Treatment for Stage IIB and IIIB Cervical Cancer Patients
    Puspitasari, Irma M.
    Legianawati, Dewi
    Sinuraya, Rano K.
    Suwantika, Auliya A.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2021, 13 : 221 - 229
  • [39] Adjuvant FOLFIRINOX in Patients with Resected Pancreatic Ductal Adenocarcinoma: A Cost-effectiveness Analysis
    Hersh, A. R.
    Buuck, T.
    Wagner, J.
    Kardosh, A.
    Caughey, A.
    Mayo, S. C.
    Billingsley, K. G.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S45 - S45
  • [40] COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB AS A SECOND-LINE THERAPY FOR ADVANCED UROTHELIAL CARCINOMA IN THE UNITED STATES
    Chen, N. C.
    McQueen, R.
    VALUE IN HEALTH, 2023, 26 (12) : S122 - S122
12345